VITASPRING BIOMEDICAL CO., LTD. (VSBC) Operating cash flow 2017–2026
VITASPRING BIOMEDICAL CO., LTD. (VSBC) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$2,688FY2026 · since FY2017: -$4,045 → -$2,688
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$2,688 | +81.7% |
| FY2025 | -$14,675 | +58.0% |
| FY2024 | -$34,920 | +55.0% |
| FY2023 | -$77,556 | +71.2% |
| FY2022 | -$269,631 | -540.0% |
| FY2021 | -$42,130 | -40023.8% |
| FY2020 | -$105 | +99.7% |
| FY2019 | -$34,248 | -8640.6% |
| FY2018 | $401 | +109.9% |
| FY2017 | -$4,045 | — |
Source: SEC XBRL filings · For reference only · Not investment advice